Key considerations to cancer institute’s gen AI deployment
CIO
JUNE 6, 2024
The overhype of generative AI was unavoidable last year, yet despite all the distraction, unproven benefits, and potential pitfalls, Dana-Farber Cancer Institute CIO Naomi Lenane didn’t want to ban the technology outright. But allowing free, unfettered use of the public gen AI platforms was not an option.
Let's personalize your content